The residency is a 52-week, ASHP-accredited, post-graduate program that
begins around July 1 annually. We accept one resident yearly. Application
deadline is Jan. 15. Early commit for KD PGY1 resident available.
Attain an “achieved for residency” on 95% of the objectives
as assessed by the Residency Program Director on the last quarterly evaluation.
100% of the Patient Care objectives must be marked as “achieved
for residency.” In order to successfully complete the program, no
areas should be marked as “needs improvement” by the residency end date.
Complete a yearlong research project.
Complete a manuscript suitable for publication and receive approval from
the project preceptor(s) and Residency Program Director.
Participate in development of the annual antibiogram and treatment guidelines.
Document coverage of all required topics from the PGY2 ID topic list.
Prepare and present two ACPE or equivalent education sessions.
Demonstrate active participation in the residency learning system/process
through participation in the evaluations of the program, learning experiences,
preceptors and self-evaluations.
Attend required professional meetings.
Participate in the recruitment efforts of the program.
Residents are expected to attend and actively participate in recruitment
events to which they are assigned.
Participate in teaching certificate program if not completed during PGY1
(offered through Marshall University School of Pharmacy).
Participate in four professional/community service events.
Prepare and participate in P&T Committee meeting presentations.
Participate in Antimicrobial Stewardship (ASC), Diagnostic Stewardship
(DxSt), and Infection Control committee meetings.
Other responsibilities may arise during the residency year. The Residency
Program Director and the resident will discuss these as they arise.
STAFFING REQUIREMENTS (EVERY THIRD WEEKEND)
Verification of antimicrobial orders
Interventions to improve antimicrobial selection and dose optimization
Dr. Reneau is the current PGY2 Pharmacy Resident in Infectious Diseases
and a 2023 graduate of the Ohio Northern University Raabe College of Pharmacy.
She completed her PGY1 at Mercy Health St. Rita’s Medical Center
in her hometown of Lima, Ohio in 2024. Dr. Reneau’s areas of interest
are outpatient parenteral antimicrobial therapy, HIV and Hepatitis, opportunistic
infections, and antimicrobial stewardship. Upon completion of residency,
she plans to work in both inpatient and outpatient antimicrobial stewardship,
and assist in an Infectious Diseases Clinic.
